UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
OMGA holding history
Omega Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OMGA overviewAll 13F holders of OMGAFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −163,904−100.0% | Sold out | Holders |
| Q4 2024 | 163,904 | $122.3K | <0.1% | +160,912+5,378.1% | Added | Holders |
| Q3 2024 | 2,992 | $3.65K | <0.1% | +1,545+106.8% | Added | Holders |
| Q2 2024 | 1,447 | $3.00K | <0.1% | −26,263−94.8% | Reduced | Holders |
| Q1 2024 | 27,710 | $101.1K | <0.1% | +99+0.4% | Added | Holders |
| Q4 2023 | 27,611 | $83.1K | <0.1% | +14,490+110.4% | Added | Holders |
| Q3 2023 | 13,121 | $28.2K | <0.1% | −1,919−12.8% | Reduced | Holders |
| Q2 2023 | 15,040 | $84.2K | <0.1% | +10,986+271.0% | Added | Holders |
| Q1 2023 | 4,054 | $24.4K | <0.1% | +2,410+146.6% | Added | Holders |
| Q4 2022 | 1,644 | $9.39K | <0.1% | −1,960−54.4% | Reduced | Holders |
| Q3 2022 | 3,604 | $20.0K | <0.1% | +3,604 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −297−100.0% | Sold out | Holders |
| Q1 2022 | 297 | $2.00K | <0.1% | −1,455−83.0% | Reduced | Holders |
| Q4 2021 | 1,752 | $20.0K | <0.1% | +768+78.0% | Added | Holders |
| Q3 2021 | 984 | $19.0K | <0.1% | +984 | New | Holders |